Skip to content

Coapt Evaluation Kit

by Coapt, LLC

Ref B618Q1Model N1

Coapt Evaluation Kit (B618Q1) is a bioelectrical signal analysis software (EU MDR Class I; FDA Class I; FDA product code IQO, Device, Prosthesis Alignment) made by Coapt, LLC, registered in EUDAMED on 10 Nov 2021 (Basic UDI-DI ++B618N18Z) and listed in FDA GUDID since 18 Nov 2019 (UDI-DI B618Q1), active as of 22 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE MDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED Number++B618N18Z Basic UDI-DI B618Q1UDI-DIDate10 Nov 2021RegisteredStatusActive
United StatesGUDID listing GUDID NumberB618Q1 UDI-DI Date18 Nov 2019ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
The Coapt Evaluation Kit is a handheld clinical tool created with technology from the Coapt COMPLETE CONTROL System Gen2. It is an accessory intended to be used during the planning and alignment of myoelectric control contact locations for an upper limb prosthetic socket.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI ++B618N18Z registered 10 Nov 2021 Active
  • FDA GUDID UDI-DI B618Q1 listed 18 Nov 2019 Listed

Timeline

2 dated events

  1. Listed FDA GUDID B618Q1
  2. Registered EUDAMED ++B618N18Z

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Generic name
Bioelectrical signal analysis software
Model / reference
N1 EUDAMED
B618Q1 EUDAMED
1 GUDID
Primary DI / UDI-DI
B618Q1
Basic UDI-DI
++B618N18Z
FDA product code
IQO
EMDN code
Y061899, Z12100492
GMDN term
Bioelectrical signal analysis software
Device class
Class I
Regulation number
890.3025
EU registration type
Standard device
EU market of registration
Sweden
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Model / referenceEUDAMED
N1
B618Q1
GUDID
1

Manufacturer details

EUDAMED SRN
US-MF-000003759
Authorised representative
Fillauer Europe AB SE-AR-000002627

Similar devices in this category

Other devices filed under ELECTROMYOGRAPHY INSTRUMENTS.

Other devices from Coapt, LLC

See all devices from Coapt, LLC →

Properties

  • Over-the-counter
  • Premarket exempt
  • Serial number
  • Manufacturing date
Other properties (21, all answered No)